<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04006470</url>
  </required_header>
  <id_info>
    <org_study_id>2019SnF2ErosionAnalysis</org_study_id>
    <nct_id>NCT04006470</nct_id>
  </id_info>
  <brief_title>Meta-analysis of Stannous Fluoride and the Effects on Enamel Erosion</brief_title>
  <official_title>Bioavailable Stannous Fluoride Dentifrice Meta-Analyses: Effects on Dentine Hypersensitivity and Enamel Erosion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Procter and Gamble</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Procter and Gamble</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this 5 study analysis was to compare the effect of bioavailable stannous fluoride
      (SnF2) dentifrices to assess enamel erosion protection in-situ using surface profilometry.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Actual">November 30, 2018</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Surface profilometry</measure>
    <time_frame>10 days</time_frame>
    <description>Enamel samples will be measured via profilometry after 10 days of study use.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">172</enrollment>
  <condition>Enamel Erosion</condition>
  <arm_group>
    <arm_group_label>Stannous Fluoride Dentifrice</arm_group_label>
    <description>Twice daily use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Positive control dentifrice</arm_group_label>
    <description>Twice daily use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Negative control dentifrice</arm_group_label>
    <description>Twice daily use</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Stannous fluoride dentifrice</intervention_name>
    <description>Stannous fluoride (0.454%) dentifrice</description>
    <arm_group_label>Stannous Fluoride Dentifrice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Positive control dentifrice</intervention_name>
    <description>Positive control dentifrice containing potassium nitrate or arginine.</description>
    <arm_group_label>Positive control dentifrice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Negative control dentifrice</intervention_name>
    <description>Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)</description>
    <arm_group_label>Negative control dentifrice</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This meta-analysis includes healthy adult male and females.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjects
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Multiple P&amp;G Investigation Clinical Sites</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>July 1, 2019</last_update_submitted>
  <last_update_submitted_qc>July 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Tin Fluorides</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

